輸入代號或公司名稱後按 Enter
4168

醣聯

-0.05 (-0.23%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
21.5554成交張數本益比2.86股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入202538年增 +157.5%
毛利率202562.1%最新一期
營業利益率2025-659.8%最新一期
每股盈餘2025-2.16
會計項目走勢20162017201820192020202120222023202420252026 預估 1 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計41.0%53.5%48.4%79.7%72.3%36.8%53.6%60.9%50.2%37.9%
營業毛利(毛損)59.0%46.5%51.6%20.3%27.7%63.2%46.4%39.1%49.8%62.1%67.0%
營業毛利(毛損)淨額59.0%46.5%51.6%20.3%27.7%63.2%46.4%39.1%49.8%62.1%
推銷費用984.9%877.0%451.5%295.4%1061.0%82.8%14.7%204.8%29.8%14.1%
管理費用16440.6%6920.5%5209.1%6666.6%11633.7%892.2%168.8%1780.9%302.7%120.4%
研究發展費用26244.4%17615.5%29119.0%29824.4%34809.5%2648.5%656.2%8276.2%1391.4%587.4%
營業費用合計43669.9%25412.9%34779.6%36786.4%47504.2%3623.5%839.6%10262.0%1723.9%721.9%
營業利益(損失)-43610.9%-25366.4%-34728.0%-36766.1%-47476.5%-3560.3%-793.2%-10222.8%-1674.1%-659.8%-415.7%
利息收入687.1%50.0%15.3%368.5%55.1%15.1%
其他收入3585.8%2400.9%2407.8%3442.9%4368.7%381.8%65.2%756.6%72.0%34.7%
其他利益及損失淨額810.5%344.0%-1976.9%-283.5%7179.8%-22.0%-2.4%2882.0%23.6%10.2%
財務成本淨額352.3%111.5%0.5%0.7%548.8%0.0%14.5%224.7%38.8%18.6%
營業外收入及支出合計4043.9%2633.4%430.3%3158.7%11686.9%409.8%62.6%3782.3%111.8%41.4%
稅前淨利(淨損)-39566.9%-22733.0%-34297.6%-33607.4%-35789.6%-3150.6%-730.7%-6440.5%-1562.3%-618.4%
所得稅費用(利益)合計1185.8%72.7%-70.5%74.8%292.7%0.0%0.0%576.1%0.2%2.9%
繼續營業單位本期淨利(淨損)-40752.7%-22805.7%-34227.1%-33682.2%-36082.3%-3150.6%-730.7%-7016.6%-1562.5%-621.3%
本期淨利(淨損)-40752.7%-22805.7%-34227.1%-33682.2%-36082.3%-3150.6%-730.7%-7016.6%-1562.5%-621.3%
確定福利計畫之再衡量數-203.8%-22.9%-29.7%-76.8%-79.2%-3.0%3.7%9.9%2.3%1.2%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益79.3%-129.7%1784.3%-94.3%-2.3%-35.6%-3.9%-9.3%
不重分類至損益之項目:-206.5%1705.1%-97.2%1.4%-25.7%-1.6%-8.1%
其他綜合損益(淨額)-10428.9%-720.0%49.6%-206.5%1705.1%-97.2%1.4%-25.7%-1.6%-8.1%
本期綜合損益總額-51181.6%-23525.7%-34177.5%-33888.7%-34377.2%-3247.8%-729.2%-7042.3%-1564.1%-629.4%
母公司業主(淨利∕損)-40752.7%-22805.7%-34227.1%-33682.2%-36082.3%-3150.6%-730.7%-7016.6%-1562.5%-621.3%-402.0%
母公司業主(綜合損益)-51181.6%-23525.7%-34177.5%-33888.7%-34377.2%-3247.8%-729.2%-7042.3%-1564.1%-629.4%
基本每股盈餘-539.7%-301.3%-451.4%-444.1%-405.8%-32.5%-7.3%-64.9%-14.4%-5.7%-3.6%
繼續營業單位淨利(淨損)-0.5%-0.3%-0.5%-0.4%-0.4%-0.0%-0.0%-0.1%-0.0%-0.0%
稀釋每股盈餘-539.7%-301.3%-451.4%-444.1%-405.8%-32.5%-7.3%-64.9%-14.4%-5.7%
預期信用減損損失(利益)1.0%0.0%
備供出售金融資產未實現評價損益-11602.9%-697.2%0.0%
與可能重分類之項目相關之所得稅-1377.8%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。